Autoimmune thyroid disease

Current Opinion in Rheumatology

Volumn 24, Issue 1, 2012, Pages 70-75

  Stathatos, Nikolaos ^a   Daniels, Gilbert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Autoimmune; Rheumatologic disorders; Thyroid disorders

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; ETANERCEPT; IPLIMUMAB; PENDRIN; PROPYLTHIOURACIL; PROTEIN ANTIBODY; RITUXIMAB; SODIUM IODIDE SYMPORTER; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; ENDOCRINE OPHTHALMOPATHY; GENERAL PRACTITIONER; GENETIC LINKAGE; GLOMERULONEPHRITIS; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; HYPERTHYROIDISM; LIVER NECROSIS; LUPUS LIKE SYNDROME; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIC PURPURA; THYROID DISEASE; THYROIDITIS;

HUMANS; THYROIDITIS, AUTOIMMUNE;

EID: 82955237251     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834ddb27     Document Type: Review

References (64)

1. Ban Y, Davies TF, Greenberg DA, et al. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): Results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002; 57: 81-88. (Pubitemid 34785888)
2. Pugliese A. Genetics of type 1 diabetes. Endocrinol Metab Clin North Am 2004; 33:1-16; vii.
3. Ban Y, Davies TF, Greenberg DA, et al. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 2004; 5:203-208. (Pubitemid 38967653)
4. Menconi F, Monti MC, Greenberg DA, et al. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A 2008; 105:14034-14039.
5. Jacobson EM, Yang H, Menconi F, et al. Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: A genetic, biochemical, and reverse immunological perspective. J Biol Chem 2009; 284:34231-34243.
6. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24:65-97.
7. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997; 46:551-554. (Pubitemid 27286927)
8. Vieland VJ, Huang Y, Bartlett C, et al. A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. Am J Hum Genet 2008; 82:1349-1356.
9. Metcalfe RA, McIntosh RS, Marelli-Berg F, et al. Detection of CD40 on human thyroid follicular cells: Analysis of expression and function. J Clin Endocrinol Metab 1998; 83:1268-1274. (Pubitemid 28496407)
10. Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 2005; 146:2684-2691. (Pubitemid 40695571)
11. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76:561-571. (Pubitemid 40432164)
12. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317-1319. (Pubitemid 41722185)
13. Tomer Y, Menconi F, Davies TF, et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 2007; 29:69-77. (Pubitemid 47385112)
14. Brand OJ, Lowe CE, Heward JM, et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 2007; 66:508-512. (Pubitemid 46434929)
15. Dechairo BM, Zabaneh D, Collins J, et al. Association of the TSHR gene with Graves' disease: The first disease specific locus. Eur J Hum Genet 2005; 13:1223-1230.
16. Czarnocka B, Ruf J, Ferrand M, et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190:147-152. (Pubitemid 16251336)
17. Mariotti S, Caturegli P, Piccolo P, et al. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990; 71:661-669. (Pubitemid 20286067)
18. Blanchin S, Estienne V, Durand-Gorde JM, et al. Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 2003; 144:5422-5429. (Pubitemid 37476071)
19. Rodien P, Madec AM, Ruf J, et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: Relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 1996; 81:2595-2600. (Pubitemid 26240283)
20. Adams DD. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J Clin Endocrinol Metab 1958; 18:699-712.
21. Michalek K, Morshed SA, Latif R, Davies TF. TSH receptor autoantibodies. Autoimmun Rev 2009; 9:113-116.
22. Sanders J, Evans M, Premawardhana LD, et al. Human monoclonal thyroid stimulating autoantibody. Lancet 2003; 362:126-128. (Pubitemid 36831025)
23. Smith BR, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 2007; 17:923-938. (Pubitemid 350071602)
24. Fenouillet E, Fayet G, Hovsepian S, et al. Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. J Biol Chem 1986; 261:15153-15158. (Pubitemid 17218090)
25. Ericsson UB, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol 1985; 37:154-162. (Pubitemid 15239401)
26. Bogner U, Hegedus L, Hansen JM, et al. Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur J Endocrinol 1995; 132: 69-74.
27. Parkes AB, McLachlan SM, Bird P, Rees Smith B. The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol 1984; 57:239-243. (Pubitemid 14083851)
28. De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000; 80:1083-1105. (Pubitemid 30452012)
29. Seissler J, Wagner S, Schott M, et al. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85:4630-4634. (Pubitemid 32157644)
30. Czarnocka B. Thyroperoxidase, thyroglobulin, Na(+)/I(-) symporter, pendrin in thyroid autoimmunity. Front Biosci 2011; 16:783-802. The study shows the role of thyroperoxidase, thyglobulin, Na/I symporter and pendrin molecules in the development of thyroid autoimmunity.
31. Hadj Kacem H, Rebai A, Kaffel N, et al. PDS is a new susceptibility gene to autoimmune thyroid diseases: Association and linkage study. J Clin Endocrinol Metab 2003; 88:2274-2280. (Pubitemid 36549908)
32. Yoshida A, Hisatome I, Taniguchi S, et al. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 2009; 94:442-448.
33. Lazurova I, Benhatchi K, Rovensky J, et al. Autoimmune thyroid disease and autoimmune rheumatic disorders: A two-sided analysis. Ann N Y Acad Sci 2009; 1173:211-216.
34. Katakura M, Yamada T, Aizawa T, et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64:405-408. (Pubitemid 17020901)
35. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335:99-107. (Pubitemid 26240112)
36. Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 2010; 95: 1309-1317. The study shows the correlation between clinical, serological, sonographic and immunologic evidence of Hashimoto's thyroiditis.
37. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007; 92:4236-4240. (Pubitemid 350074737)
38. Vanderpump MP. How should we manage patients with mildly increased serum thyrotrophin concentrations? Clin Endocrinol (Oxf) 2010; 72:436-440.
39. Sieiro Netto L, Medina Coeli C, Micmacher E, et al. Influence of thyroid autoimmunity and maternal age on the risk of miscarriage. Am J Reprod Immunol 2004; 52:312-316. (Pubitemid 39585718)
40. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91:2587-2591. (Pubitemid 44024622)
41. Lazarus JH, Parkes AB, Premawardhana LD. Postpartum thyroiditis. Autoimmunity 2002; 35:169-173. (Pubitemid 34678737)
42. Doutre MS. Chronic urticaria and thyroid auto-immunity. Clin Rev Allergy Immunol 2006; 30:31-37.
43. Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010; 362:726-738. This article is a review of Graves' ophthalmopathy.
44. Nakamori Y, Tominaga T, Inoue Y, Shinohara K. Propylthiouracil (PTU)- induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA). Intern Med 2003; 42:529-533. (Pubitemid 36926819)
45. Jodar E, Munoz-Torres M, Escobar-Jimenez F, et al. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause. Clin Endocrinol (Oxf) 1997; 47:279-285. (Pubitemid 27395958)
46. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 1994; 73:1-7.
47. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987; 16:409-415. (Pubitemid 18088084)
48. Nixon DW, Samols E. Acral changes associated with thyroid diseases. JAMA 1970; 212:1175-1181.
49. Hsu SI, Thadhani RI, Daniels GH. Acute compartment syndrome in a hypothyroid patient. Thyroid 1995; 5:305-308.
50. Tullu MS, Udgirkar VS, Muranjan MN, et al. Kocher-Debre-Semelaigne syndrome: Hypothyroidism with muscle pseudohypertrophy. Indian J Pediatr 2003; 70:671-673. (Pubitemid 37107892)
51. Madariaga MG. Polymyositis-like syndrome in hypothyroidism: Review of cases reported over the past twenty-five years. Thyroid 2002; 12:331-336.
52. Katz JN, Larson MG, Sabra A, et al. The carpal tunnel syndrome: Diagnostic utility of the history and physical examination findings. Ann Intern Med 1990; 112:321-327. (Pubitemid 20083606)
53. Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002; 12:977-988. (Pubitemid 35404132)
54. Weetman AP. Diseases associated with thyroid autoimmunity: Explanations for the expanding spectrum. Clin Endocrinol (Oxf) 2011; 74:411-418. The study shows clinical association between thyroid autoimmunity and other disorders in humans.
55. Barbesino G. Drugs affecting thyroid function. Thyroid 2010; 20:763-770. The article is a detailed description of drugs known to affect thyroid function.
56. Canas CA, Tobon GJ, Arango LG, Guarin N. Developing of granulomatous thyroiditis during etanercept therapy. Clin Rheumatol 2009; 28 (Suppl 1): S17-S19.
57. Allanore Y, Bremont C, Kahan A, Menkes CJ. Transient hyperthyroidism in a patient with rheumatoid arthritis treated by etanercept. Clin Exp Rheumatol 2001; 19:356-357. (Pubitemid 32529840)
58. van Lieshout AW, Creemers MC, Radstake TR, et al. Graves' disease in a patient with rheumatoid arthritis during treatment with antitumor necrosis factor-alpha. J Rheumatol 2008; 35:938-939. (Pubitemid 351747144)
59. Raterman HG, Jamnitski A, Lems WF, et al. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: A pilot study. J Rheumatol 2011; 38:247-251.
60. Atzeni F, Doria A, Ghirardello A, et al. Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: A prospective long-term follow-up. Autoimmunity 2008; 41:87-91.
61. Khanna D, Chong KK, Afifiyan NF, et al. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 2010; 117:133-139.
62. Raterman HG, Simsek S, Lems WF, et al. Rituximab and thyroid function. Arch Intern Med 2009; 169:1073-1074.
63. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 2007; 36:1051-1066; x-xi. (Pubitemid 350026253)
64. Coles AJ, Compston DA, Selmaj KW, et al. Alemtuzumab vs. interferon beta- 1a in early multiple sclerosis. N Engl J Med 2008; 359:1786-1801.